| # | % | |||||
|---|---|---|---|---|---|---|
| 251 | DHT HOLDINGS INC COM | 100,000 | 576,000 | 0.01% | ||
| 252 | AMICUS THERAPEUTICS INC | 59,900 | 506,000 | 0.00% | Call | |
| 253 | TRIMBLE INC | 17,770 | 441,000 | 0.00% | ||
| 254 | CATALYST PHARMACEUTICALS INC | 358,078 | 419,000 | 0.00% | ||
| 255 | FLAMEL TECHNOLOGIES SA SPONSORED ADR | 30,355 | 335,000 | 0.00% | ||
| 256 | AMEDISYS INC COM | 6,560 | 317,000 | 0.00% | ||
| 257 | AKAMAI TECH | 5,340 | 297,000 | 0.00% | ||
| 258 | MACROGENICS INC | 11,144 | 209,000 | 0.00% | ||
| 259 | Ixia | 12,616 | 157,000 | 0.00% | ||
| 260 | VONAGE HLDGS CORP COM | 34,283 | 157,000 | 0.00% |
Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0001085146-16-003567, filed 2016.05.03).
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.
